Stockman B J, Scahill T A, Strakalaitis N A, Brunner D P, Yem A W, Deibel M R
Upjohn Laboratories, Upjohn Company, Kalamazoo, MI 49007.
FEBS Lett. 1994 Jul 25;349(1):79-83. doi: 10.1016/0014-5793(94)00643-1.
Interleukin-1 receptor antagonist protein (IRAP) is a naturally occurring inhibitor of the interleukin-1 receptor. In contrast to IL-1 beta, IRAP binds to the IL-1 receptor but does not elicit a physiological response. We have determined the solution structure of IRAP using NMR spectroscopy. While the overall topology of the two 153-residue proteins is quite similar, functionally critical differences exist concerning the residues of the linear amino acid sequence that constitute structurally homologous regions in the two proteins. Structurally homologous residues important for IL-1 receptor binding are conserved between IRAP and IL-1 beta. By contrast, structurally homologous residues critical for receptor activation are not conserved between the two proteins.
白细胞介素-1受体拮抗剂蛋白(IRAP)是一种天然存在的白细胞介素-1受体抑制剂。与白细胞介素-1β不同,IRAP与白细胞介素-1受体结合但不引发生理反应。我们利用核磁共振光谱法确定了IRAP的溶液结构。虽然这两种含153个残基的蛋白质的整体拓扑结构非常相似,但在构成这两种蛋白质结构同源区域的线性氨基酸序列的残基方面存在功能上的关键差异。对白细胞介素-1受体结合重要的结构同源残基在IRAP和白细胞介素-1β之间是保守的。相比之下,对受体激活至关重要的结构同源残基在这两种蛋白质之间并不保守。